BSE filing, BSE: 544445. Summary written from the filing by ALFA Finder's alert engine.
Asston Pharmaceuticals Ltd: key numbers
- Share price
- ₹146.25
- Market cap
- ₹124.5 Cr
- Revenue (annual)
- ₹25.47 Cr
- Net profit (annual)
- ₹3.87 Cr
- P/E (TTM)
- 32.2×Sector 46.1×
- Promoter holding
- 39.48%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Asston Pharmaceuticals Ltd
All →Asston Pharmaceuticals Other Announcement
Asston Pharmaceuticals Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026. It also disclosed a recent preferential allotment of 24.10 lakh equity shares.
Asston Pharmaceuticals Other Announcement
Asston Pharmaceuticals Limited announced a change in the company's registered office address within the same city, effective from 15th October 2026.
Asston Pharmaceuticals Capital Structure Change
The company submitted a revised shareholding pattern following the allotment of 24,10,431 equity shares through a preferential allotment dated September 5, 2026.
Asston Pharmaceuticals Other Announcement
Asston Pharmaceuticals Limited has appointed M/s. Panchal S K & Associates as its Statutory Auditor for a five-year term. The appointment is effective from April 1, 2026.
- Execution
- 60 months
Asston Pharmaceuticals Annual General Meeting
Asston Pharmaceuticals Limited concluded its 7th Annual General Meeting on September 29, 2026. Shareholders considered resolutions including adoption of financial statements and director remuneration increases.
Asston Pharmaceuticals Other Announcement
Asston Pharmaceuticals Ltd submitted its quarterly shareholding pattern disclosure, detailing the shareholding status of promoters and public shareholders for the period ended March 2026.
Other board meeting date announcements
All →Sharvaya Metals Board Meeting Date
Sharvaya Metals intimates that its Board of Directors is scheduled to meet on 6 November 2026. The agenda includes approval of half-year unaudited results.
Matrimony.com Board Meeting Date
Matrimony.com will hold its board meeting on November 10, 2026, to approve unaudited Q2 and H1 results. Trading window closes October 1 to November 12.
S D Retail Board Meeting Date
S D Retail scheduled a board meeting on 5 Nov 2026 to review half-yearly unaudited results for September 2026. The trading window remains closed until 7 Nov 2026.
Futuristic Solutions Board Meeting Date
Futuristic Solutions Ltd scheduled a board meeting on November 6, 2026 to consider Q1 FY27 financial results. Trading window stays closed until declaration.
Sayaji Hotels Board Meeting Date
Sayaji Hotels Ltd scheduled its Board meeting for November 3, 2026, to approve Q3 and H1 FY27 results. The trading window is closed pending declaration.
Precision Wires India Board Meeting Date
Precision Wires scheduled a Board Meeting on 6 Nov 2026 to consider Q2/H1 results and an interim dividend. The meeting has not yet been held; agenda items are proposed only.